These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35674078)

  • 1. Is calcitonin gene-related peptide a reliable biochemical marker of migraine?
    Tesfay B; Karlsson WK; Moreno RD; Hay DL; Hougaard A
    Curr Opin Neurol; 2022 Jun; 35(3):343-352. PubMed ID: 35674078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
    Kamm K; Straube A; Ruscheweyh R
    Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
    Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
    Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
    Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
    Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
    Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
    Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiological role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache].
    Meßlinger K
    Schmerz; 2020 Apr; 34(2):181-187. PubMed ID: 32103345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
    Ramón C; Cernuda-Morollón E; Pascual J
    Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
    Yuan H; Spare NM; Silberstein SD
    Headache; 2019 Jul; 59 Suppl 2():20-32. PubMed ID: 31291020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review.
    Tfelt-Hansen P; Le H
    J Headache Pain; 2009 Jun; 10(3):137-43. PubMed ID: 19330286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-calcitonin gene-related peptide monoclonal antibodies for neuropathic pain in patients with migraine headache.
    Kang SA; Govindarajan R
    Muscle Nerve; 2021 Apr; 63(4):563-567. PubMed ID: 33347632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
    Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
    JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
    Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
    J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series.
    Iannone LF; Fattori D; Geppetti P; De Cesaris F
    Neurol Sci; 2022 Jan; 43(1):697-703. PubMed ID: 34586542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.
    Schuster NM; Rapoport AM
    Clin Neuropharmacol; 2017; 40(4):169-174. PubMed ID: 28644160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
    Khan S; Olesen A; Ashina M
    Cephalalgia; 2019 Mar; 39(3):374-389. PubMed ID: 29110503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGRP in human models of primary headaches.
    Ashina H; Schytz HW; Ashina M
    Cephalalgia; 2018 Feb; 38(2):353-360. PubMed ID: 27940880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of anti-CGRP antibodies in the pathophysiology of primary headaches.
    Barbanti P; Aurilia C; Fofi L; Egeo G; Ferroni P
    Neurol Sci; 2017 May; 38(Suppl 1):31-35. PubMed ID: 28527063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.
    Rees TA; Hendrikse ER; Hay DL; Walker CS
    Br J Pharmacol; 2022 Feb; 179(3):381-399. PubMed ID: 34187083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack?
    Vural S; Albayrak L
    J Recept Signal Transduct Res; 2022 Dec; 42(6):562-566. PubMed ID: 35895308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
    Cady RK; Vause CV; Ho TW; Bigal ME; Durham PL
    Headache; 2009 Oct; 49(9):1258-66. PubMed ID: 19788468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.